Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes (the DEPICT-2 Study): 24-Week Results From a Randomized Controlled Trial.

Diabetes Care
C MathieuDEPICT-2 Investigators

Abstract

This 24-week, double-blinded, phase 3 clinical trial (DEPICT-2; ClinicalTrials.gov, NCT02460978) evaluated efficacy and safety of dapagliflozin as adjunct therapy to adjustable insulin in patients with inadequately controlled type 1 diabetes (HbA1c 7.5-10.5%). Patients were randomized 1:1:1 to dapagliflozin 5 mg (n = 271), dapagliflozin 10 mg (n = 270), or placebo (n = 272) plus insulin. Insulin dose was adjusted by investigators according to self-monitored glucose readings, local guidance, and individual circumstances. Baseline characteristics were balanced between treatment groups. At week 24, dapagliflozin significantly decreased HbA1c (primary outcome; difference vs. placebo: dapagliflozin 5 mg -0.37% [95% CI -0.49, -0.26], dapagliflozin 10 mg -0.42% [-0.53, -0.30]), total daily insulin dose (-10.78% [-13.73, -7.72] and -11.08% [-14.04, -8.02], respectively), and body weight (-3.21% [-3.96, -2.45] and -3.74% [-4.49, -2.99], respectively) (P < 0.0001 for all). Mean interstitial glucose, amplitude of glucose excursion, and percent of readings within target glycemic range (>70 to ≤180 mg/dL) versus placebo were significantly improved. More patients receiving dapagliflozin achieved a reduction in HbA1c ≥0.5% without severe hypo...Continue Reading

References

May 25, 2005·Diabetic Medicine : a Journal of the British Diabetic Association·L A DonnellyUNKNOWN DARTS/MEMO Collaboration
Oct 4, 2005·Current Medical Research and Opinion·Ruth E DavisCraig J Currie
Oct 11, 2007·Diabetes, Obesity & Metabolism·David Russell-Jones, Rehman Khan
May 23, 2009·Journal of the American College of Cardiology·Carl J LavieHector O Ventura
Jul 1, 2009·Diabetes Care·Abbas E KitabchiJoseph N Fisher
May 6, 2011·Diabetes Care·Brian M FrierSimon R Heller
Oct 2, 2013·Indian Journal of Endocrinology and Metabolism·Sanjay KalraAmbady Ramachandran
Nov 20, 2014·The New England Journal of Medicine·Marcus LindAnnika Rosengren
Dec 17, 2014·Diabetic Medicine : a Journal of the British Diabetic Association·J A McKnightK M Miller
May 23, 2015·Diabetes Care·Kellee M MillerUNKNOWN T1D Exchange Clinic Network
Aug 5, 2016·The Journal of Clinical Endocrinology and Metabolism·Nitesh D KuhadiyaParesh Dandona
Sep 14, 2017·The New England Journal of Medicine·Satish K GargPaul Strumph

❮ Previous
Next ❯

Citations

Nov 22, 2018·Diabetes Care·Matthew C Riddle, William T Cefalu
Dec 1, 2018·The Annals of Pharmacotherapy·Diana IsaacsSanela Lekic
Feb 26, 2019·Diabetic Medicine : a Journal of the British Diabetic Association·L A Wright, I B Hirsch
May 14, 2019·Diabetes, Obesity & Metabolism·Torben BiesterThomas Danne
Jul 19, 2019·Diabetes/metabolism Research and Reviews·Bingwen LiuZhiguang Zhou
Jun 10, 2019·Diabetes Care·Bruce A PerkinsNima Soleymanlou
May 22, 2019·Diabetes Care·Joseph I Wolfsdorf, Robert E Ratner
Aug 1, 2019·Diabetes, Obesity & Metabolism·Emma G WilmotMike Baxter
Oct 31, 2019·Drugs·Julia Paik, Hannah A Blair
Sep 10, 2019·Diabetic Medicine : a Journal of the British Diabetic Association·A J SinclairUNKNOWN an International Group of Experts
Mar 5, 2020·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Sanjay KalraJignesh K Ved
Dec 15, 2019·The Journal of Clinical Endocrinology and Metabolism·David R PowellPablo Lapuerta
Apr 11, 2020·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Jason GordonPhil McEwan
Nov 2, 2019·Current Drug Targets·Ping WuHao Fang
Jun 4, 2020·Journal of Diabetes Science and Technology·Theocharis KoufakisKalliopi Kotsa
May 16, 2020·British Medical Bulletin·Andrea Llano, Gerard A McKay
Dec 10, 2019·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Marc EvansUmesh Dashora

❮ Previous
Next ❯

Related Concepts

Related Feeds

American Diabetes Association Journals

Discover the latest diabetes research published by the journals from the American Diabetes Association.